| 15/02/22 | 14:32:47 | 15 Feb 2022 | | PDS Clinical Trial with Mayo Clinic |
| 02/02/22 | 15:00:01 | 2 Feb 2022 | | PDS Phase 2 Trial Update |
| 28/01/22 | 08:45:21 | 28 Jan 2022 | | PDS Announces Preclinical Data for PDS0202 Vaccine |
| 18/01/22 | 07:00:06 | 18 Jan 2022 | | Holding(s) in Company |
| 10/01/22 | 14:20:06 | 10 Jan 2022 | | PDS Granted Novel HPV16 Immunotherapy Patent |
| 10/01/22 | 07:00:10 | 10 Jan 2022 | | ProAxsis CEO End of Year Update |
| 29/12/21 | 08:47:53 | 29 Dec 2021 | | Issue of Equity |
| 21/12/21 | 13:59:13 | 21 Dec 2021 | | TR-1: Form for notification of major holdings |
| 21/12/21 | 07:00:04 | 21 Dec 2021 | | Q-Bot Investment and Share Acquisition |
| 20/12/21 | 07:00:06 | 20 Dec 2021 | | Acquisition of majority stake in Cetromed |
| 13/12/21 | 07:00:07 | 13 Dec 2021 | | Martlet Capital Update |
| 06/12/21 | 14:53:12 | 6 Dec 2021 | | PDS Phase 2 Clinical Trial Update |
| 26/11/21 | 07:00:07 | 26 Nov 2021 | | $1million investment in portfolio company, EpiBone |
| 10/11/21 | 13:58:01 | 10 Nov 2021 | | PDS Reports Q3 2021 Results & Business Update |
| 04/11/21 | 07:00:05 | 4 Nov 2021 | | Sofant Signs EUR7.3m ESA Contract |
| 01/11/21 | 14:16:24 | 1 Nov 2021 | | PDS to License Novel Proteins for Flu Vaccine |
| 26/10/21 | 07:00:05 | 26 Oct 2021 | | EMV Capital Participates in £843k Sofant Funding |
| 22/10/21 | 11:18:59 | 22 Oct 2021 | | ProAxsis announces the approval of a key US patent |
| 22/10/21 | 09:04:11 | 22 Oct 2021 | | Holding(s) in Company |
| 21/10/21 | 16:40:37 | 21 Oct 2021 | | Second Price Monitoring Extn |
| 21/10/21 | 16:35:35 | 21 Oct 2021 | | Price Monitoring Extension |
| 21/10/21 | 14:17:10 | 21 Oct 2021 | | PDS Phase 2 Clinical Trial Update |
| 05/10/21 | 07:00:08 | 5 Oct 2021 | | PDS Phase 2 Clinical Trial Update |
| 04/10/21 | 07:00:08 | 4 Oct 2021 | | Investor Presentations |
| 30/09/21 | 10:22:30 | 30 Sept 2021 | | Holding(s) in Company |
| 29/09/21 | 07:00:10 | 29 Sept 2021 | | Grant of Options to Directors |
| 29/09/21 | 07:00:07 | 29 Sept 2021 | | Interim Results |
| 20/09/21 | 07:00:08 | 20 Sept 2021 | | Notice of Results and Analyst Briefing |
| 16/09/21 | 07:00:03 | 16 Sept 2021 | | Investment in Martlet Capital Limited |
